GMED
Undervalued by 19% based on the discounted cash flow analysis.
Market cap | $7.20 Billion |
---|---|
Enterprise Value | $7.19 Billion |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $0.54 |
Beta | 1.03 |
Outstanding Shares | 112,624,816 |
Avg 30 Day Volume | 1,330,149 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 108.1 |
---|---|
PEG | -94.42 |
Price to Sales | 4.03 |
Price to Book Ratio | 1.89 |
Enterprise Value to Revenue | 3.79 |
Enterprise Value to EBIT | 41.43 |
Enterprise Value to Net Income | 107 |
Total Debt to Enterprise | 0.06 |
Debt to Equity | 0.11 |
No data
No data